Company: NCEL
Filing Date: 2025-07-18
Form Type: F-4/A
Source: 0001213900-25-065783
Chunk: 828

Company: NewcelX Ltd.
Filing Date: 2025-07-18
Form: F-4/A
Chunk 828
---
4 million, and the remaining amount, USD $0.6 million, was received in cash from Mr. Ruggieri. On December 7, 2021, the general meeting of shareholders authorized the Investment Agreements. On December 23, 2021, the full consideration was received and the transaction was completed. H.On November 23, 2021, the Board of Directors approved a private placement agreement (the “Placement”) in the amount of USD $3.2 million (the “Investment Amount”) with Ilex Medical Ltd (hereinafter, the “Investor”). The agreement with the Investor was signed on November 24, 2021. As part of the Placement, the Investor would be issued 2,345,216 ordinary shares. In addition, the Investor would be issued 1,407,130 non -marketablewarrants eligible for conversion into 1,407,130 marketable shares without consideration. The offered warrants would be issued in two series. The warrants’ exercise prices would be USD $2.3 and USD $2.7. The warrants would be exercisable from the date of their issuance until December 31, 2023 and December 31, 2024, respectively. The full consideration was received on December 28, 2021, and the Company issued shares and warrants in accordance with the Placement Agreement. As of December 31, warrants totaling 70,356 had expired. I.On December 12, 2022, the shareholders’ meeting approved the increase of the Company’s authorized share capital by 50,000,000shares, no par value, and the capital increase, respectively, so that after the capital increase, the authorized share capital of the Company was USD $2.9 million, divided into 100,000,000 ordinary shares. On December 12, 2022, the Company published a shelf offering by way of rights. Under the shelf offering, shares were offered by way of rights to the Company’s shareholders, in such a way that each shareholder who held 100 Shares would be entitled to purchase 1 rights unit. 1 rights unit consisted of 32 Shares, and the total price of each rights unit was USD $10. The total number of rights units offered was up to 14,623,392 rights units. Until December 31, 2022, the Company received notices for 47,574 rights (in exchange for which 1,522,335shares were issued as of the